These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 31575873

  • 1. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A, Sailer C, Ryu S, Catone N, Stankovic-Valentin N, Schmidtke G, Melchior F, Stengel F, Groettrup M.
    Nat Commun; 2019 Oct 01; 10(1):4452. PubMed ID: 31575873
    [Abstract] [Full Text] [Related]

  • 2. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J, Groettrup M, Aichem A.
    PLoS One; 2015 Oct 01; 10(3):e0120329. PubMed ID: 25768649
    [Abstract] [Full Text] [Related]

  • 3. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
    Sha Z, Blyszcz T, González-Prieto R, Vertegaal ACO, Goldberg AL.
    J Biol Chem; 2019 Oct 18; 294(42):15218-15234. PubMed ID: 31285264
    [Abstract] [Full Text] [Related]

  • 4. Mechanistic studies on activation of ubiquitin and di-ubiquitin-like protein, FAT10, by ubiquitin-like modifier activating enzyme 6, Uba6.
    Gavin JM, Chen JJ, Liao H, Rollins N, Yang X, Xu Q, Ma J, Loke HK, Lingaraj T, Brownell JE, Mallender WD, Gould AE, Amidon BS, Dick LR.
    J Biol Chem; 2012 May 04; 287(19):15512-22. PubMed ID: 22427669
    [Abstract] [Full Text] [Related]

  • 5. Ang II Promotes SUMO2/3 Modification of RhoGDI1 Through Aos1 and Uba2 Subunits, and then Regulates RhoGDI1 Stability and Cell Proliferation.
    Qi Y, Guan H, Liang X, Sun J, Yao W.
    Cardiovasc Drugs Ther; 2021 Aug 04; 35(4):769-773. PubMed ID: 33891248
    [Abstract] [Full Text] [Related]

  • 6. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
    Schmidtke G, Kalveram B, Groettrup M.
    FEBS Lett; 2009 Feb 04; 583(3):591-4. PubMed ID: 19166848
    [Abstract] [Full Text] [Related]

  • 7. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
    Aichem A, Catone N, Groettrup M.
    FEBS J; 2014 Apr 04; 281(7):1848-59. PubMed ID: 24528925
    [Abstract] [Full Text] [Related]

  • 8. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
    Hirano S, Udagawa O.
    Arch Toxicol; 2022 Feb 04; 96(2):545-558. PubMed ID: 35001170
    [Abstract] [Full Text] [Related]

  • 9. The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.
    Boehm AN, Bialas J, Catone N, Sacristan-Reviriego A, van der Spuy J, Groettrup M, Aichem A.
    J Biol Chem; 2020 Oct 16; 295(42):14402-14418. PubMed ID: 32817338
    [Abstract] [Full Text] [Related]

  • 10. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G, Maroui MA, Dutrieux J, Dianoux L, Nisole S, Chelbi-Alix MK.
    J Immunol; 2015 Sep 01; 195(5):2312-24. PubMed ID: 26223657
    [Abstract] [Full Text] [Related]

  • 11. FAT10ylation as a signal for proteasomal degradation.
    Schmidtke G, Aichem A, Groettrup M.
    Biochim Biophys Acta; 2014 Jan 01; 1843(1):97-102. PubMed ID: 23333871
    [Abstract] [Full Text] [Related]

  • 12. The SUMO2/3 specific E3 ligase ZNF451-1 regulates PML stability.
    Koidl S, Eisenhardt N, Fatouros C, Droescher M, Chaugule VK, Pichler A.
    Int J Biochem Cell Biol; 2016 Oct 01; 79():478-487. PubMed ID: 27343429
    [Abstract] [Full Text] [Related]

  • 13. Structures of UBA6 explain its dual specificity for ubiquitin and FAT10.
    Truongvan N, Li S, Misra M, Kuhn M, Schindelin H.
    Nat Commun; 2022 Aug 15; 13(1):4789. PubMed ID: 35970836
    [Abstract] [Full Text] [Related]

  • 14. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
    Schimmel J, Larsen KM, Matic I, van Hagen M, Cox J, Mann M, Andersen JS, Vertegaal AC.
    Mol Cell Proteomics; 2008 Nov 15; 7(11):2107-22. PubMed ID: 18565875
    [Abstract] [Full Text] [Related]

  • 15. FAT10 : Activated by UBA6 and Functioning in Protein Degradation.
    Pelzer C, Groettrup M.
    Subcell Biochem; 2010 Nov 15; 54():238-46. PubMed ID: 21222287
    [Abstract] [Full Text] [Related]

  • 16. Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10.
    Aichem A, Boehm AN, Catone N, Schmidtke G, Groettrup M.
    Methods Enzymol; 2019 Nov 15; 618():229-256. PubMed ID: 30850054
    [Abstract] [Full Text] [Related]

  • 17. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
    Bialas J, Boehm AN, Catone N, Aichem A, Groettrup M.
    J Biol Chem; 2019 Mar 22; 294(12):4315-4330. PubMed ID: 30718280
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML.
    Weisshaar SR, Keusekotten K, Krause A, Horst C, Springer HM, Göttsche K, Dohmen RJ, Praefcke GJ.
    FEBS Lett; 2008 Sep 22; 582(21-22):3174-8. PubMed ID: 18708055
    [Abstract] [Full Text] [Related]

  • 19. UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10.
    Wang F, Zhao B.
    Int J Mol Sci; 2019 May 07; 20(9):. PubMed ID: 31067743
    [Abstract] [Full Text] [Related]

  • 20. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
    Aichem A, Pelzer C, Lukasiak S, Kalveram B, Sheppard PW, Rani N, Schmidtke G, Groettrup M.
    Nat Commun; 2010 May 04; 1():13. PubMed ID: 20975683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.